VI
BMY.RT

Vestcor Inc’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Vestcor Inc’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-137,500
Closed -$95K – 1303
2020
Q4 		$95K Buy
137,500
+107,500
+358% +$229K ﹤0.01% 861
2020
Q3 		$68K Buy
30,000
+25,000
+500% +$71.4K ﹤0.01% 817
2020
Q2 		$18K Sell
5,000
-124,009
-96% -$447K ﹤0.01% 825
2020
Q1 		$490K Sell
129,009
-187,354
-59% -$617K 0.03% 408
2019
Q4 		$952K Buy
+316,363
New +$823K 0.04% 360

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Vestcor Inc's BMY.RT Position: Q1 2021 in Review

Vestcor Inc sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 137,500 shares — an estimated $95K sold.

Vestcor Inc first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $952K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Vestcor Inc reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Vestcor Inc sold 137,500 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $95K.
  • Vestcor Inc first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Vestcor Inc's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $952K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Vestcor Inc's 13F filing for Q1 2021, filed 17 May 2021.